← Clinical Cases
Transplant — clinical cases
29 questions
Sample cases
- Case 1
A 45-year-old man receives a deceased-donor kidney transplant. He is at low immunologic risk (first transplant, no donor-specific antibodies) and receives basiliximab induction. According to KDIGO, which maintenance regimen is preferred?
- A.Tacrolimus plus mycophenolate, with or without prednisone
- B.Cyclosporine plus azathioprine, with or without prednisone
- C.Sirolimus plus mycophenolate started on the day of surgery
- D.Mycophenolate plus prednisone without a calcineurin inhibitor
- Case 2
A 38-year-old woman with three previous pregnancies and a failed first kidney graft is receiving a second kidney transplant. Her calculated panel-reactive antibody is 92%. Which induction approach do KDIGO guidelines suggest for her?
- A.An interleukin-2 receptor antagonist such as basiliximab
- B.No biologic induction, with high-dose tacrolimus from day 1
- C.A lymphocyte-depleting antibody such as rabbit anti-thymocyte globulin
- D.Intravenous immunoglobulin alone in place of antibody induction
- Case 3
A 52-year-old man is on day 3 of rabbit anti-thymocyte globulin induction after kidney transplantation. Today's labs: WBC 2.6 ×109/L (2,600/mm3), platelets 140 ×109/L (140,000/mm3). According to the US prescribing information, what should be done with today's dose?
- A.Give the full planned dose with closer monitoring
- B.Stop anti-thymocyte globulin for the rest of the course
- C.Give one-quarter of the planned dose
- D.Give one-half of the planned dose
